Clinical Trial Update: Safety and Efficacy of Intravenous Natalizumab in Acute Ischemic Stroke [Phase 2]

View source ↗

Summary

Phase 2 trial assessing safety and efficacy of intravenous natalizumab in patients with acute ischemic stroke has completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Natalizumab (natalizumab)

Snippet

Sponsor: Biogen | Conditions: Acute Ischemic Stroke | Phase 2 | Status: COMPLETED | Results posted: 2019-01-08